Role of inflammasome NLRP3 in the pathophysiology of viral infections: A focus on SARS-CoV-2 infection

被引:3
|
作者
Chemarin, Marlene [1 ]
Dufies, Oceane [2 ]
Mazet, Anastassia [1 ]
Mellan, Eva [2 ]
Coudereau, Remy [3 ,4 ]
Py, Benedicte F. [1 ]
Boyer, Laurent [2 ]
Venet, Fabienne [1 ,3 ]
机构
[1] Univ Claude Bernard Lyon 1, Univ Lyon, CIRI,Ctr Int Rech infectiol, CNRS,UMR5308,ENS Lyon,Inserm,U1111, F-69007 Lyon, France
[2] Univ Cote Azur, INSERM, C3M, Nice, France
[3] Hop Edouard Herriot, Hosp civils Lyon, Lab immunol, F-69437 Lyon 03, France
[4] Univ Claude Bernard Lyon 1, Hosp civils Lyon, BioMerieux Unite Mixte Rech HCL BioMerieux, EA 7426 Pathophysiol Injury Induced, F-69003 Lyon, France
来源
M S-MEDECINE SCIENCES | 2022年 / 38卷 / 6-7期
关键词
COVID-19; CANAKINUMAB;
D O I
10.1051/medsci/2022080
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
NLRP3 is one of the best characterized innate immune cytosolic sensor. As part of the innate immune response, the NLRP3 inflammasome detects a wide range of danger signals such as pathogens, tissue damages, cellular stress. The priming and activation of NLRP3 lead to the formation of an oligomeric intracellular complex and to the recruitment and activation of caspase-1. Once activated, not only this inflammasome complex controls the processing and release of pro-inflammatory factors including IL-1 beta and IL-18, but also the inflammatory cell death pyroptosis mediated by gasdermin D pores. In this review, we describe the role of the NLRP3 inflammasome activation in viral infections with a particular interest on SARS-CoV-2 infection. In addition, we present therapies evaluated or under evaluation targeting the NLRP3 inflammasome pathway as COVID-19 treatment.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 50 条
  • [11] Blocking the action of NLRP3 inflammasome by inhaled ibuprofenate on pulmonary macrophages infected by SARS-CoV-2
    Zurita-Lizza, Christian Carlos
    Rodriguez-Sanchez, Ignacio
    Doreski, Pablo Alexis
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2023, 3 (01):
  • [12] SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
    Eduardo A. Albornoz
    Alberto A. Amarilla
    Naphak Modhiran
    Sandra Parker
    Xaria X. Li
    Danushka K. Wijesundara
    Julio Aguado
    Adriana Pliego Zamora
    Christopher L. D. McMillan
    Benjamin Liang
    Nias Y. G. Peng
    Julian D. J. Sng
    Fatema Tuj Saima
    Jenny N. Fung
    John D. Lee
    Devina Paramitha
    Rhys Parry
    Michael S. Avumegah
    Ariel Isaacs
    Martin W. Lo
    Zaray Miranda-Chacon
    Daniella Bradshaw
    Constanza Salinas-Rebolledo
    Niwanthi W. Rajapakse
    Ernst J. Wolvetang
    Trent P. Munro
    Alejandro Rojas-Fernandez
    Paul R. Young
    Katryn J. Stacey
    Alexander A. Khromykh
    Keith J. Chappell
    Daniel Watterson
    Trent M. Woodruff
    Molecular Psychiatry, 2023, 28 : 2878 - 2893
  • [13] SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
    Albornoz, Eduardo A.
    Amarilla, Alberto A.
    Modhiran, Naphak
    Parker, Sandra
    Li, Xaria X.
    Wijesundara, Danushka K.
    Aguado, Julio
    Zamora, Adriana Pliego
    McMillan, Christopher L. D.
    Liang, Benjamin
    Peng, Nias Y. G.
    Sng, Julian D. J.
    Saima, Fatema Tuj
    Fung, Jenny N.
    Lee, John D.
    Paramitha, Devina
    Parry, Rhys
    Avumegah, Michael S.
    Isaacs, Ariel
    Lo, Martin W.
    Miranda-Chacon, Zaray
    Bradshaw, Daniella
    Salinas-Rebolledo, Constanza
    Rajapakse, Niwanthi W.
    Wolvetang, Ernst J.
    Munro, Trent P.
    Rojas-Fernandez, Alejandro
    Young, Paul R.
    Stacey, Katryn J.
    Khromykh, Alexander A.
    Chappell, Keith J.
    Watterson, Daniel
    Woodruff, Trent M.
    MOLECULAR PSYCHIATRY, 2023, 28 (07) : 2878 - 2893
  • [14] Role of the Nlrp3 inflammasome in microbial infection
    Anand, Paras K.
    Malireddi, R. K. Subbarao
    Kanneganti, Thirumala-Devi
    FRONTIERS IN MICROBIOLOGY, 2011, 2
  • [15] Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection
    La Rosa, Giusy Rita Maria
    Libra, Massimo
    De Pasquale, Rocco
    Ferlito, Sebastiano
    Pedulla, Eugenio
    FRONTIERS IN MEDICINE, 2021, 7
  • [16] SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation
    Jeong, Jae Seok
    Choi, Jin Young
    Kim, Jong Seung
    Park, Seong Ok
    Kim, Wankyu
    Yoon, Yeo-Gha
    Park, Hae Jin
    Park, Kyung Hwa
    Kim, Doo Hwan
    Kim, Jung Mo
    Koh, Gou Young
    Eo, Seong Kug
    Lee, Yong Chul
    ALLERGY, 2023, 78 (01) : 287 - 290
  • [17] SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine “storm” and risk factor for damage of hematopoietic stem cells
    Mariusz Z. Ratajczak
    Magda Kucia
    Leukemia, 2020, 34 : 1726 - 1729
  • [18] SARS-CoV-2 Infection in Severe Asthma Is Associated With Worsening of COVID-19 Through Respiratory NLRP3 Inflammasome Activation
    Jeong, J.
    Kim, J.
    Kim, S.
    Park, H.
    Park, K.
    Lee, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [19] SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells
    Ratajczak, Mariusz Z.
    Kucia, Magda
    LEUKEMIA, 2020, 34 (07) : 1726 - 1729
  • [20] The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection
    Lecuyer, Deborah
    Nardacci, Roberta
    Tannous, Desiree
    Gutierrez-Mateyron, Emie
    Nathan, Aurelia Deva
    Subra, Frederic
    Di Primio, Cristina
    Quaranta, Paola
    Petit, Vanessa
    Richetta, Clemence
    Mostefa-Kara, Ali
    Del Nonno, Franca
    Falasca, Laura
    Marlin, Romain
    Maisonnasse, Pauline
    Delahousse, Julia
    Pascaud, Juliette
    Deprez, Eric
    Naigeon, Marie
    Chaput, Nathalie
    Paci, Angelo
    Saada, Veronique
    Ghez, David
    Mariette, Xavier
    Costa, Mario
    Pistello, Mauro
    Allouch, Awatef
    Delelis, Olivier
    Piacentini, Mauro
    Le Grand, Roger
    Perfettini, Jean-Luc
    FRONTIERS IN IMMUNOLOGY, 2023, 14